[Federal Register Volume 68, Number 169 (Tuesday, September 2, 2003)]
[Notices]
[Page 52224]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-22331]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on May 2, 2003, Cambrex Charles 
City, Inc., 1205 11th Street, Charles City, Iowa 50619, made 
application by letter to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of Dextropropoxyphene (9273), a 
basic class of Schedule II controlled substance.
    The firm plans to manufacture bulk controlled substance for 
distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCD) and must be filed no later than November 3, 2003.

    Dated: August 19, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-22331 Filed 8-29-03; 8:45 am]
BILLING CODE 4410-09-M